As a leading voice in the plant medicine and psychedelic medicine space and the founder of the Mind Army, an organization “Fighting For The Right to Pursue Happiness” I’ve witnessed firsthand the transformative power these substances have on individuals struggling with mental health and addiction. Now, more than ever, our nation is in dire need of innovative solutions to these crises. With the next election approaching, it’s crucial that we ask the presidential candidates about their stance on legalizing and making these healing medicines accessible to all Americans.
The COVID-19 pandemic exacerbated many underlying issues, leading to a surge in mental health problems and addiction rates. Both Presidents Biden and Trump navigated the country through these tumultuous times, but as we emerge from the pandemic, we face a new challenge: a population experiencing mass PTSD. The evidence supporting the safety and efficacy of plant medicines, such as psilocybin mushrooms, in treating these conditions is overwhelming. The question now is, which candidate will take the bold step to legalize and make these therapies accessible?
Historically, the Biden/Harris administration has shown a willingness to explore progressive healthcare solutions. Reports suggest that Hunter Biden had a positive experience using plant medicine to overcome his addiction, sparking hope that the administration might consider broader legalization. However, the political climate often polarizes such issues, making it challenging to enact change. Vice President Harris has the opportunity to champion this cause, potentially transforming American healthcare by making safer, plant-based treatments more accessible. These natural medicines could replace traditional anti-depressants and alcohol, which often come with severe side effects, offering a safer and more effective alternative.
On the other hand, Donald Trump has demonstrated a pragmatic approach to healthcare, particularly with his ‘Right to Try’ initiative, which empowers individuals to use unapproved treatments in desperate circumstances. This initiative underscores a fundamental belief in personal sovereignty over one’s body, a principle that aligns with the ethos of the psychedelic movement. The younger members of Trump’s organization, understanding the economic benefits of a mentally healthy and productive workforce, might also advocate for these treatments. Legalizing psychedelics could potentially reduce addiction and suicide rates, issues that are currently crippling our society.
Both candidates have the chance to make a historic impact. By committing to the legalization and accessibility of psychedelics, they can address the suicide epidemic and the fentanyl addiction crisis that ravages our nation. This commitment could also resonate deeply with a wide voter base. In the Midwest, for example, ‘Moms on Mushrooms’ are already experiencing the benefits of microdosing psilocybin and are sharing their positive outcomes with others. These mothers, who often make the health decisions for their families, are a powerful demographic that could sway the election.
Trump’s stance on the ‘Right to Try’ could be extended to include psychedelics, offering veterans and others suffering from PTSD and addiction a new hope. It’s reported that 20 times as many soldiers who died in combat have subsequently died by suicide. Providing access to these medicines could be the most significant contribution any president has made to veterans’ health.
A candidate who commits to this cause with integrity could win the election by a landslide, attracting voters who have directly experienced the healing potential of psychedelics. This issue transcends typical political divisions, touching the lives of individuals across the spectrum. It’s time for both Biden/Harris and Trump to let the American people know where they stand on this crucial issue.
Let’s have this important conversation on podcasts and media platforms, pushing candidates to make their plans for psychedelic medicine clear. The mental health and productivity of our population depend on it.
By engaging in this dialogue, we can ensure that the next president prioritizes the health and well-being of all Americans through access to these transformative treatments.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.